Correlation Between Capricor Therapeutics and Achilles Therapeutics
Can any of the company-specific risk be diversified away by investing in both Capricor Therapeutics and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Capricor Therapeutics and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Capricor Therapeutics and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Capricor Therapeutics and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Capricor Therapeutics with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Capricor Therapeutics and Achilles Therapeutics.
Diversification Opportunities for Capricor Therapeutics and Achilles Therapeutics
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Capricor and Achilles is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Capricor Therapeutics and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Capricor Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Capricor Therapeutics are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Capricor Therapeutics i.e., Capricor Therapeutics and Achilles Therapeutics go up and down completely randomly.
Pair Corralation between Capricor Therapeutics and Achilles Therapeutics
Given the investment horizon of 90 days Capricor Therapeutics is expected to under-perform the Achilles Therapeutics. In addition to that, Capricor Therapeutics is 2.5 times more volatile than Achilles Therapeutics PLC. It trades about -0.11 of its total potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about 0.22 per unit of volatility. If you would invest 99.00 in Achilles Therapeutics PLC on August 29, 2024 and sell it today you would earn a total of 8.00 from holding Achilles Therapeutics PLC or generate 8.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Capricor Therapeutics vs. Achilles Therapeutics PLC
Performance |
| Timeline |
| Capricor Therapeutics |
| Achilles Therapeutics PLC |
Capricor Therapeutics and Achilles Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Capricor Therapeutics and Achilles Therapeutics
The main advantage of trading using opposite Capricor Therapeutics and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Capricor Therapeutics position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.| Capricor Therapeutics vs. Bio Path Holdings | Capricor Therapeutics vs. NextCure | Capricor Therapeutics vs. Pulmatrix | Capricor Therapeutics vs. Akari Therapeutics PLC |
| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |